Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 4
1946 10
1947 12
1948 14
1949 6
1950 31
1951 48
1952 71
1953 49
1954 36
1955 58
1956 35
1957 26
1958 49
1959 72
1960 68
1961 65
1962 91
1963 182
1964 264
1965 197
1966 163
1967 213
1968 278
1969 286
1970 303
1971 262
1972 299
1973 340
1974 377
1975 309
1976 346
1977 344
1978 386
1979 385
1980 321
1981 273
1982 271
1983 304
1984 287
1985 311
1986 311
1987 323
1988 319
1989 324
1990 427
1991 480
1992 533
1993 601
1994 584
1995 656
1996 607
1997 695
1998 797
1999 899
2000 935
2001 1250
2002 1535
2003 1637
2004 1640
2005 1932
2006 1748
2007 1770
2008 1712
2009 1714
2010 1770
2011 1824
2012 1695
2013 1745
2014 1672
2015 1551
2016 1455
2017 1317
2018 1172
2019 545
2020 16
Text availability
Article attribute
Article type
Publication date

Search Results

44,049 results
Results by year
Filters applied: . Clear all
Page 1
Closing the drug lag for new drug submission and review in Japan: An industry perspective.
Poirier AF. Clin Pharmacol Ther 2015 - Review. PMID 26239646
Previous publications have focused on drug lag in Japan and the government's initiatives to address the situation.(1) Japan is the third largest pharmaceutical market, and yet has experienced significant drug lag for many years. This article reviews the progress resulting from industry adaptation of new regulatory paradigms that include Japan in global drug development programs....
Previous publications have focused on drug lag in Japan and the government's initiatives to address the situation.(1) Japan is the th …
Lessons from a Recovering Academic
Ehlers MD. Cell 2016. PMID 27203106 Free article.
The conversion of basic biology into new therapeutics requires scientific activities in both academia and industry. Successful drug discovery projects span disciplines, sectors, and institutions and tightly couple laboratory and clinical experiments. Here, Ehlers describes conceptions and misconceptions about how science is conducted in industry versus academia....
The conversion of basic biology into new therapeutics requires scientific activities in both academia and industry. Successful dru
Development and Innovation of Ganoderma Industry and Products in China.
Li Z, et al. Adv Exp Med Biol 2019 - Review. PMID 31677144
The modern research and development of Ganoderma industry started from the 1950s, in which the successful cultivation of Ganoderma fruiting body and submerged fermentation of Ganoderma mycelium lay the critical foundation for the industry development. Recent decades have witnessed the rapid development of Ganoderma industry, which is boosted through various efforts made by the government, the academia, and the industry. ...
The modern research and development of Ganoderma industry started from the 1950s, in which the successful cultivation of Ganoderma fr …
Q&A: Bernard Munos
Bender E. Nature 2016. PMID 27167392
Introduction
Light DW. J Health Polit Policy Law 2014. PMID 24603084
Development Considerations for Nanocrystal Drug Products.
Chen ML, et al. AAPS J 2017 - Review. PMID 28281194
To date, the US Food and Drug Administration (FDA) has received over 80 applications for drug products containing nanocrystals. ...Impact of food on drug bioavailability was reduced for most nanocrystal formulations as compared with their micronized counterparts. ...
To date, the US Food and Drug Administration (FDA) has received over 80 applications for drug products containing nanocrystals …
Bayer joins CRISPR
[No authors listed] Nat Biotechnol 2016. PMID 26849501
44,049 results
Jump to page
Feedback